Potassium Citrate Tablet, Extended Release
Product Images NDC 72162-2120

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 72162-2120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Table 1. (Table 1.)

Table 1. (Table 1.)
Table 1 shows the effect of Potassium Citrate in patients with Calcium Oxalate Nephrolithiasis. The table presents the number of stones formed per year in different groups of patients. The groups are labeled as Group Baseline, Group I, Group II, Group III, and Group IV. The table also includes the baseline data, the data on treatment, the remission rate, and the percentage of any decrease in stone formation. The total number of patients included in the study is 89. Remission is defined as the percentage of patients remaining free of newly formed stones during treatment.*
FDA Label Image

Label (Lbl721622120)

Label (Lbl721622120)
This text appears to be a description of a medication called "Potassium Citrate Extended-Release Tablets, USP 10 mEq." The tablets are uncoated and are capsule-shaped, with a debossed imprint of "T400" on one side and a plain surface on the other side. The tablets are off white to tan yellowish in color. Each tablet contains 10 milliequivalents (mEq) or 1080 milligrams (mg) of potassium citrate. The tablets are labeled with the National Drug Code (NDC) 72162-2120-1. The medication should be stored at a temperature between 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit), with excursions allowed between 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). It should be kept out of the reach of children and dispensed in a tightly closed container with a child-resistant closure. The medication is manufactured by Ascent Pharmaceuticals, Inc. and relabeled by Bryant Ranch Prepack, Inc. at their facility in Burbank, CA, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.